Woodline Partners LP Zentalis Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,055,282 shares of ZNTL stock, worth $4.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,055,282

Previous 1,517,077 30.44%

Holding current value

$4.17 Million

Previous $6.2 Million 37.59%

% of portfolio

0.04%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.9 - $4.57 $1.34 Million - $2.11 Million	-461,795 Reduced 30.44%	1,055,282 $3.87 Million
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $327,408 - $1.29 Million	80,051 Added 5.57%	1,517,077 $6.2 Million
Q1 2024 May 15, 2024	BUY	$10.83 - $16.49 $362,512 - $551,969	33,473 Added 2.38%	1,437,026 $22.6 Million
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $3.97 Million - $8.12 Million	403,553 Added 40.36%	1,403,553 $21.3 Million
Q3 2023 Nov 14, 2023	SELL	$19.63 - $28.29 $1.86 Million - $2.69 Million	-94,974 Reduced 8.67%	1,000,000 $20.1 Million
Q2 2023 Aug 14, 2023	SELL	$17.41 - $30.05 $18.6 Million - $32.2 Million	-1,070,577 Reduced 49.44%	1,094,974 $30.9 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $32.6 Million - $50.4 Million	2,019,032 Added 1378.0%	2,165,551 $37.2 Million
Q4 2022 Feb 14, 2023	SELL	$18.07 - $25.6 $3.13 Million - $4.43 Million	-173,228 Reduced 54.18%	146,519 $2.95 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $2.8 Million - $4.39 Million	138,475 Added 76.39%	319,747 $6.93 Million
Q2 2022 Aug 15, 2022	BUY	$17.91 - $52.25 $2.52 Million - $7.34 Million	140,524 Added 344.86%	181,272 $5.09 Million
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $13.6 Million - $26.5 Million	-327,425 Reduced 88.93%	40,748 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $9.35 Million - $11.8 Million	-139,674 Reduced 27.5%	368,173 $30.9 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $101,714 - $159,642	2,172 Added 0.43%	507,847 $33.8 Million
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $13.5 Million - $22.5 Million	361,514 Added 250.77%	505,675 $26.9 Million
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $148,506 - $219,367	4,161 Added 2.97%	144,161 $6.26 Million
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $67,098 - $122,664	2,116 Added 1.53%	140,000 $7.27 Million
Q3 2020 Nov 16, 2020	BUY	$27.03 - $47.97 $2.55 Million - $4.52 Million	94,158 Added 215.34%	137,884 $4.51 Million
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $1.01 Million - $2.4 Million	43,726 New	43,726 $2.1 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

68.1M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $225M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Zentalis Pharmaceuticals, Inc. Transaction History